Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000755806 | SCV000883387 | uncertain significance | not provided | 2018-02-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001343491 | SCV001537478 | uncertain significance | HNSHA due to aldolase A deficiency | 2022-08-11 | criteria provided, single submitter | clinical testing | This sequence change replaces histidine, which is basic and polar, with tyrosine, which is neutral and polar, at codon 246 of the ALDOA protein (p.His246Tyr). This variant is present in population databases (rs144693278, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with ALDOA-related conditions. ClinVar contains an entry for this variant (Variation ID: 617972). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ce |
RCV000755806 | SCV004146221 | uncertain significance | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | ALDOA: PM2, BP4 |
Mayo Clinic Laboratories, |
RCV000755806 | SCV004227555 | uncertain significance | not provided | 2022-08-25 | criteria provided, single submitter | clinical testing | BP4 |
Revvity Omics, |
RCV001343491 | SCV004239002 | uncertain significance | HNSHA due to aldolase A deficiency | 2023-08-01 | criteria provided, single submitter | clinical testing |